Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol

View/ Open
Abstract
To determine the prevalence of previous hepatitis A virus [HAV] infection in people chronically infected with hepatitis B virus [HBV], we assessed the prevalence of anti-HAV IgG in 392 patients. The study was carried out in Babol, northern Islamic Republic of Iran from September 2004 to March 2005. Prevalence in those aged 10-19 years was 59.4% and was significantly lower than that in those aged 20-29 years [89.8%] and those over 29 years [97.5%]. There was no significant difference in prevalence according to sex or place of residence. A significant proportion of Iranian adolescents and young adults with chronic HBV infection are at risk of contracting HAV infectionCitation
Roushan, M.R.H., Bijani, A., Sagheb, R. & Jazayeri, O. (2007). Prevalence of hepatitis A IgG in individuals with chronic hepatitis B infection in Babol. http://www.who.int/iris/handle/10665/117355
Relation
EMHJ - Eastern Mediterranean Health Journal, 13 (5), 1108-1113, 2007
Description
1108-1113ISSN
1020-3397Other Identifiers
http://applications.emro.who.int/emhj/1305/13_5_2007_1108_1113.pdfCollections
Language
EnglishMetadata
Show full item recordRelated items
Showing items related by title and MeSH subject.
-
Know it. Confront it.: Hepatitis affects over 500 million people. It could affect you.: This is Hepatitis: World Hepatitis Day, 28 July
World Health Organization, Regional Office for the Eastern Mediterranean (WHO-EM/CSR/062/E, 2013) -
Know it. Confront it.: Hepatitis affects over 500 million people. It could affect you.: This is Hepatitis: World Hepatitis Day, 28 July
World Health Organization, Regional Office for the Eastern Mediterranean (WHO-EM/CSR/061/E, 2013) -
Inmunización contra la Hepatitis B : introducción de la vacuna contra la hepatitis B en los servicios nacionales de inmunización
World Health Organization. Dept. of Vaccines and Biologicals (WHO/V&B/01.28, 2001)